89 results match your criteria: "UCL Elizabeth Garrett Anderson Institute for Women's Health[Affiliation]"

Objective: Multidisciplinary team (MDT) meetings are assumed to produce better decisions and are extensively used to manage chronic disease in the National Health Service (NHS). However, evidence for their effectiveness is mixed. Our objective was to investigate determinants of MDT effectiveness by examining factors influencing the implementation of MDT treatment plans.

View Article and Find Full Text PDF

A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control.

Bioinformatics

August 2014

Computational Systems Genomics, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China, Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health and Statistical Genomics Group, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UKComputational Systems Genomics, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China, Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health and Statistical Genomics Group, Paul O'Gorman Building, UCL Cancer Institute, University College London, London WC1E 6BT, UK.

Motivation: There is a growing number of studies generating matched Illumina Infinium HumanMethylation450 and gene expression data, yet there is a corresponding shortage of statistical tools aimed at their integrative analysis. Such integrative tools are important for the discovery of epigenetically regulated gene modules or molecular pathways, which play key roles in cellular differentiation and disease.

Results: Here, we present a novel functional supervised algorithm, called Functional Epigenetic Modules (FEM), for the integrative analysis of Infinium 450k DNA methylation and matched or unmatched gene expression data.

View Article and Find Full Text PDF

CANCER IN OTHER WORDS? THE ROLE OF METAPHOR IN EMOTION DISCLOSURE IN CANCER PATIENTS.

Br J Psychother

May 2013

Dept. of Women's Cancer, the UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, Medical School Building 74 Huntley Street London WC1E 6AU.

Despite evidence that nurses may play a crucial part in the wellbeing and recovery of cancer patients by facilitating their expression of feelings, research is lacking into the emotional content of nurse-patient talk and patients' use of language in emotion disclosure. In this study, 23 participating nurses in a variety of cancer care settings were asked to tape-record their conversations with patients during daily care. A data set of 60 nurse-patient conversations was collected.

View Article and Find Full Text PDF

Implementing an obstetric ultrasound training program in rural Africa.

Int J Gynaecol Obstet

March 2014

Academic Department of Maternal and Fetal Medicine, UCL Elizabeth Garrett Anderson Institute for Women's Health, London, UK; Medical Aid Films, London, UK. Electronic address:

Objective: To evaluate the feasibility and sustainability of basic obstetric ultrasound training in rural Africa.

Methods: An 8-week training course, led by UK-based sonographers, was supported by training videos and followed by 10 months of remotely supported scanning in Mandimba, Mozambique. Data were collected prospectively using an Android tablet and the EpiCollect web application.

View Article and Find Full Text PDF

Follow-up protocols for women with cervical cancer after primary treatment.

Cochrane Database Syst Rev

November 2013

Department of Women's Cancer, The UCL Elizabeth Garrett Anderson Institute for Women's Health, Medical School Building, 74 Huntley St, London, UK, WC1E 6AU.

Background: Cervical cancer is the second most common cancer among women up to 65 years of age and is the most frequent cause of death from gynaecological cancers worldwide. Although surveillance of women after completion of primary treatment for cervical cancer is purported to have an impact on their overall survival (OS), no strictly defined follow-up protocols are available for these women. Wide diversity in management has been noted in the follow-up of women who have completed primary treatment for cervical cancer.

View Article and Find Full Text PDF

Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.

PLoS Med

November 2013

Department of Women's Cancer, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom.

Background: Endometrial cancer incidence is continuing to rise in the wake of the current ageing and obesity epidemics. Much of the risk for endometrial cancer development is influenced by the environment and lifestyle. Accumulating evidence suggests that the epigenome serves as the interface between the genome and the environment and that hypermethylation of stem cell polycomb group target genes is an epigenetic hallmark of cancer.

View Article and Find Full Text PDF

Over the past decade it has become clear that cancer is an epigenetic and a genetic disease. While we have begun to understand the impact of variations in the DNA sequence on cancer development, it is only more recently that we have appreciated the significant contribution of the epigenome to carcinogenesis and cancer biology. Twin studies demonstrate that genetics makes little contribution to the development of women-specific cancers and that the 'epigenome,' the interphase between genome and environment, is likely to confer the largest component of risk.

View Article and Find Full Text PDF

Problem: The objective was to investigate placental inflammation in chromosomally normal miscarriages in vivo and in vitro.

Method Of Study: Chorionic villous tissue was collected from missed miscarriages and normal gestation-matched controls and cultured at 6 and 20% O(2) concentrations. Tissue was karyotyped.

View Article and Find Full Text PDF

The European society of gynaecological oncology: update on objectives and educational and research activities.

Am Soc Clin Oncol Educ Book

April 2016

From the European Society of Gynaecological Oncology, the UCL Elizabeth Garrett Anderson Institute for Women's Health, and the University of Milan Bicocca, European Institute of Oncology.

The European Society of Gynaecological Oncology (ESGO) is the principal European society contributing to the study, prevention, and treatment of gynecologic cancers. Founded in 1983, ESGO has more than 1,300 members in more than 40 European countries and worldwide who benefit from ESGO's innovative education and research initiatives and networking opportunities. ESGO objectives have been recently identified through a strategic planning process and include education, care, research, collaboration, awareness, and sustainability.

View Article and Find Full Text PDF

In vitro three-dimensional modelling of human ovarian surface epithelial cells.

Cell Prolif

June 2009

Gynaecological Cancer Research Laboratories, UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

Objectives: Ninety percent of malignant ovarian cancers are epithelial and thought to arise from the ovarian surface epithelium (OSE). We hypothesized that biological characteristics of primary OSE cells would more closely resemble OSE in vivo if established as three-dimensional (3D) cultures.

Materials And Methods: OSE cells were cultured as multicellular spheroids (MCS) (i) in a rotary cell culture system (RCCS) and (ii) on polyHEMA-coated plastics.

View Article and Find Full Text PDF

The legal framework for end-of-life decisions in the UK.

Semin Fetal Neonatal Med

October 2008

UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London Hospitals, London, UK.

We have reviewed the current UK guidance regarding withholding and withdrawing life-prolonging treatment in the infant and termination of pregnancy for fetal malformation. We provide summaries of the key cases. The framework provided by professional bodies and the law in this difficult area stresses the importance of good and frequent communication between different professional groups and parents with early recourse to second opinions if a difference of view emerges.

View Article and Find Full Text PDF

Outcome after intrapartum hypoxic ischaemia at term.

Semin Fetal Neonatal Med

October 2007

UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London Hospitals, Huntley Street, London WC1E 6DH, UK.

We consider the range of childhood disabilities that have been attributed to perinatal hypoxic ischaemia at term and review the strength of evidence for each. The strongest evidence is for a causal link between acute profound hypoxic ischaemia and dyskinetic tetraplegic cerebral palsy (CP). Hemiplegic CP is not usually due to a perinatal hypoxic ischaemic insult at term; an important cause is focal cerebral infarction or 'stroke'.

View Article and Find Full Text PDF

Patients diagnosed with von Hippel-Lindau disease (vHL) require life-long surveillance for this multi-system disease. It is therefore important to assess the comprehensiveness of screening provision, as well as identify what type of screening service is most likely to encourage regular patient attendance. This descriptive study reports on two types of screening service: single appointment One Stop (OS) clinics and multiple appointment Ad Hoc (AH) clinics.

View Article and Find Full Text PDF

Familial ovarian cancer screening.

Best Pract Res Clin Obstet Gynaecol

April 2006

UCL Elizabeth Garrett Anderson Institute for Women's Health, Elizabeth Garrett Anderson Hospital, University College London, Huntley Street, London WC1E 6DH, UK.

Familial predisposition accounts for approximately 10% of epithelial ovarian cancer. Identification and management of at-risk families is therefore an important area that bridges gynaecological and clinical genetic practice. The efficacy of screening for ovarian cancer in both high- and low-risk populations is currently of unproven benefit and is associated with some risks related to false-positive results.

View Article and Find Full Text PDF